Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2022

View Archived Issues

TMID enzymes as potential antiviral targets for the treatment of HHV infections

Researchers improve cisplatin-induced ototoxicity model

Anti-VISTA HMBD-002 antibody blocks VISTA-induced immunosuppression in preclinical models

Chinese researchers identify new CRBN modulators

Eccogene divulges new GLP-1R agonists

Reaction Biology presents new HDAC inhibitors

Challenge Bioproducts synthesizes new PTGER4 ligands

Customization of regulatory elements in hearing loss gene therapies using AAVAnc80 vectors

Zp Spv 3 K/S describes complement C3 inhibitors

Advanced prostate cancer antibody successful in dogs

Researchers unveil new miRNAs tied to cerebral cavernous angioma

PNV-5032 reduces airflow resistance by 25% in animal test of allergen-induced asthma

Akso and Huadong Medicine sign collaborative agreement for AB-002 in Asia Pacific region

Investigators find a role for miR-206 in intracerebral hemorrhage

JR-14a shows potent neuroprotective effect in stroke models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...